The SETD2 gene helps your cells package DNA correctly, control which genes are active, and repair DNA damage. When it does not work properly, cells can grow in a less controlled way or make more copying mistakes. This gene plays an important role in normal growth and brain development. Pathogenic variants in the SETD2 gene can cause a condition with overgrowth, developmental delay, and learning differences, and acquired SETD2 variants are also found in several cancers.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes hold the directions for producing proteins, the parts of cells that do the work. Others mainly help control when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in LearnHub.
Overview
SETD2Gene function
What if the gene works
The SETD2 gene helps cells package DNA and turn other genes on or off at the right time. It also supports DNA repair and accurate copying of genetic information during cell division.
Risk
What if the gene does not work
Inherited variants in the SETD2 gene can cause an overgrowth and neurodevelopmental condition, often with developmental delay; milder and more severe variants can change when features appear and how marked they are. Acquired variants are also linked to some cancers.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the SETD2 gene is currently established for people with a pathogenic variant. In cancer research, loss of the SETD2 gene is being studied as a biomarker and possible treatment target, especially in kidney cancer and some blood cancers.
Conditions associated with SETD2
Gene function
What if the gene works
Inside many cells, the SETD2 gene helps keep everyday gene activity organized and DNA in good working order. Its protein places a small chemical tag on proteins that package DNA, helping cells read genes, process RNA messages, and manage repair. Understanding how the SETD2 gene works can make it easier to see how cells stay stable during normal growth and renewal.
The SETD2 gene adds a small chemical tag to histones, the proteins that wrap and organize DNA. This tag helps cells mark stretches of DNA that are actively being used.
That histone tag helps the cell's reading machinery move through active genes in an orderly way. It supports steady gene activity so the right cell instructions can be copied into RNA.
After a gene is read, the RNA message still needs editing before it can guide protein making. SETD2-linked marking helps cells trim and join these messages in the right places.
The same marking system helps direct repair proteins to spots that need attention. This is one way the SETD2 gene helps repair DNA as cells deal with normal wear and tear.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Many SETD2 gene variants shorten the protein or alter the part that carries out its chemical job, so cells add less of an important chemical tag to DNA packing proteins. This can weaken DNA repair and make gene reading less controlled. Milder variants may leave some activity in place, while more severe variants can greatly reduce or stop it and are often linked to earlier or more noticeable features in SETD2-related conditions.
How variants are linked to conditions
Pathogenic variants in the SETD2 gene cause Luscan-Lumish syndrome, a condition linked with tall growth, a larger head size, developmental delay, learning differences, and sometimes autism features. When doctors discuss SETD2 gene variants and associated conditions, this is the main well-established inherited diagnosis. Acquired SETD2 variants are also found in some cancers, especially kidney cancer and certain blood cancers, but those tissue changes are different from inheriting a SETD2 variant.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and instead represent normal human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are also involved. In some situations, though, one well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risks related to the SETD2 gene. For many living with a SETD2 change, risk depends most on the exact gene change itself and personal or family history, so discussing your situation with a doctor or genetic counselor can help put that risk in context.
Inheritance of SETD2 variants
For the main inherited condition linked to the SETD2 gene, SETD2-related variants are inherited in an autosomal dominant pattern. This means a parent carrying a disease-causing variant in one copy of the SETD2 gene can pass it to a child with a 50% chance in each pregnancy, regardless of sex. In families wondering how SETD2 variants are inherited, it is also important to know that some people have a new, de novo variant that was not inherited from either parent. Once present, that variant can then be passed on in an autosomal dominant way.
What does my SETD2 result mean for my family?
A harmful change in the SETD2 gene is usually linked to a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. Each child of someone with a disease-causing SETD2 change has a 1 in 2, or 50%, chance of inheriting it. Some SETD2 changes happen new in one person, so a parent may not have the change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SETD2 gene, doctors use genetic testing for SETD2 variants on a blood or saliva sample, and sometimes on tumor tissue. A lab reads the DNA code to look for changes. Results can show whether a variant is present and whether it is inherited or limited to the tumor.
When should I consider getting a genetic test?
Genetic testing for the SETD2 gene may be considered when a child has unusual overgrowth, a larger-than-average head size, and developmental or learning differences, especially if autism is also present. It can also help when a close family member has a confirmed SETD2 variant or a diagnosis linked to this gene.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it reveals depends on the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, have less effect in another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect their response to medicines. It studies connections between genes and drugs to help explain why the same treatment can work differently in different people. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment choices that are both better informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SETD2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. Questions about side effects, new symptoms, or how a medicine may work for you are best discussed with your doctor. Research on SETD2 is ongoing, especially in cancer, where changes in the gene may affect how some tumors respond to certain treatments, but this is not yet standard prescribing guidance.
History
SETD2 came into view as researchers worked to map the genes involved in cell growth and cancer. In recent decades, awareness of this gene’s role has grown as studies linked changes in SETD2 to kidney cancer and several other conditions. It was first studied under a different name, HYPB, before scientists recognized it as SETD2 and clarified where it fits in human genetics. Building on this early work, scientists uncovered more about the gene through large cancer sequencing projects in the 2010s, which showed that SETD2 variants appear repeatedly in certain tumors. These findings helped move SETD2 from a little-known research target to an established part of modern cancer genetics.